Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Copper - Nutraceuticals World
Research

Copper

Indication: Alzheimer’s disease

Source: J Alzheimers Dis, September 2005;8(1):23-7.

Research: In this study, investigators looked into the ability of copper to stabilize cognitive decline in patients suffering from Alzheimer’s disease. Plasma copper levels were measured in over 30 patients suffering from mild to moderate Alzheimer’s disease. In addition, researchers also measured subjects’ cognitive abilities using the Alzheimer’s disease Assessment Scale-cognitive subscale (ADAS-cog).

Results: While all of the subjects in the study were found to have copper levels between 65 and 165 Ìg/dL, over 87% of them exhibited a negative correlation between plasma copper levels and cognitive decline. Those with medium plasma copper levels made fewer mistakes in the memory test compared those with low plasma copper levels. Researchers claim this finding supports the hypothesis of a mild copper deficiency in most Alzheimer patients. As such, they believe supplementation with copper might be necessary to stave off cognitive decline in Alzheimer’s patients.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters